Breast Cancer (Pharmacokinetics)

Study Provide Clues for Designing Better Cancer Drugs

Published in Women's Health Weekly, January 4th, 1999

Researchers from the University of Chicago Medical Center in Illinois and from the Howard Hughes Medical Institute at the University of California at San Francisco have discovered the molecular mechanism by which tamoxifen blocks the effects of estrogen, a process that has been shown to prevent breast cancer in some women at high risk.

The results, published in the December 23, 1998, issue of Cell, provide valuable clues about ways to design new, more effective disease-preventing medications with fewer side effects.

"The goal is to figure out how to make drugs that retain the benefits of estrogen for brain, bone, and heart and also have the benefits...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1999-01-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry